| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 474.06M | 287.30M | 941.53M | 1.00B | 914.21M | 1.27B |
| Gross Profit | 65.83M | 54.22M | 130.30M | 177.62M | 131.74M | 160.23M |
| EBITDA | -36.04M | 17.15M | -29.16M | 74.86M | 23.54M | 42.76M |
| Net Income | -111.74M | -2.86M | -128.70M | 44.71M | -34.59M | -4.30M |
Balance Sheet | ||||||
| Total Assets | 249.56M | 241.39M | 543.62M | 661.34M | 618.82M | 707.08M |
| Cash, Cash Equivalents and Short-Term Investments | 5.69M | 72.10M | 136.40M | 157.37M | 85.21M | 50.18M |
| Total Debt | 44.87M | 44.36M | 124.84M | 129.48M | 114.92M | 119.86M |
| Total Liabilities | 110.62M | 100.86M | 273.45M | 291.86M | 284.44M | 337.37M |
| Stockholders Equity | 131.25M | 132.52M | 262.89M | 361.62M | 327.85M | 361.71M |
Cash Flow | ||||||
| Free Cash Flow | 25.11M | -1.26M | -2.92M | 67.01M | 40.57M | -14.45M |
| Operating Cash Flow | 29.58M | 2.26M | 3.83M | 77.71M | 46.40M | -5.92M |
| Investing Cash Flow | -2.65M | -7.68M | 2.09M | -10.41M | 2.48M | -8.39M |
| Financing Cash Flow | -13.03M | -7.20M | -17.17M | -24.02M | -28.28M | -33.85M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £218.57M | 7.15 | 9.00% | 7.08% | 7.41% | -34.98% | |
65 Neutral | £1.59B | 10.92 | 105.88% | 3.99% | 4.39% | -1.37% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | £659.95M | 15.12 | -113.93% | 1.40% | 3.94% | ― | |
53 Neutral | £45.00M | 4.70 | 63.25% | ― | -2.65% | -18.90% | |
47 Neutral | £76.22M | -0.86 | -56.70% | ― | -38.65% | -792.57% | |
44 Neutral | £600.86M | -4.10 | -90.46% | 4.48% | -30.52% | -2064.92% |